1 |
ADRA2A
💬
| 2件: cGMP-PKG signaling pathway cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction | Dexmedetomidine
Dexmedetomidine
💬
|
Dexmedetomidine
| 14件: 2 2, 4, 6, 21, 34, 46, 70, 107, 113, 171, 212, 215, 226, 280 💬 |
2 |
ADRA2B
💬
| 2件: cGMP-PKG signaling pathway cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction | Dexmedetomidine
Dexmedetomidine
💬
|
Dexmedetomidine
| 14件: 2 2, 4, 6, 21, 34, 46, 70, 107, 113, 171, 212, 215, 226, 280 💬 |
3 |
ADRA2C
💬
| 2件: cGMP-PKG signaling pathway cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction | Dexmedetomidine
Dexmedetomidine
💬
|
Dexmedetomidine
| 14件: 2 2, 4, 6, 21, 34, 46, 70, 107, 113, 171, 212, 215, 226, 280 💬 |
4 |
GRIN1
💬
| 18件: Ras signaling pathway Ras signaling pathway, Rap1 signaling pathway, Calcium signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Circadian entrainment, Long-term potentiation, Glutamatergic synapse, Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Spinocerebellar ataxia, Prion disease, Pathways of neurodegeneration - multiple diseases, Cocaine addiction, Amphetamine addiction, Nicotine addiction, Alcoholism | Esketamine
Esketamine
💬
|
Esketamine
| 3件: 2 2, 4, 70 💬 |
5 |
GRIN1
💬
| 18件: Ras signaling pathway Ras signaling pathway, Rap1 signaling pathway, Calcium signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Circadian entrainment, Long-term potentiation, Glutamatergic synapse, Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Spinocerebellar ataxia, Prion disease, Pathways of neurodegeneration - multiple diseases, Cocaine addiction, Amphetamine addiction, Nicotine addiction, Alcoholism | Ketamine
Ketamine
💬
|
Ketamine
| 8件: 2 2, 4, 6, 13, 70, 113, 156, 215 💬 |
6 |
GRIN2A
💬
| 19件: Ras signaling pathway Ras signaling pathway, Rap1 signaling pathway, Calcium signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Circadian entrainment, Long-term potentiation, Glutamatergic synapse, Dopaminergic synapse, Alzheimer disease, Amyotrophic lateral sclerosis, Spinocerebellar ataxia, Prion disease, Pathways of neurodegeneration - multiple diseases, Cocaine addiction, Amphetamine addiction, Nicotine addiction, Alcoholism, Systemic lupus erythematosus | Esketamine
Esketamine
💬
|
Esketamine
| 3件: 2 2, 4, 70 💬 |
7 |
GRIN2A
💬
| 19件: Ras signaling pathway Ras signaling pathway, Rap1 signaling pathway, Calcium signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Circadian entrainment, Long-term potentiation, Glutamatergic synapse, Dopaminergic synapse, Alzheimer disease, Amyotrophic lateral sclerosis, Spinocerebellar ataxia, Prion disease, Pathways of neurodegeneration - multiple diseases, Cocaine addiction, Amphetamine addiction, Nicotine addiction, Alcoholism, Systemic lupus erythematosus | Ketamine
Ketamine
💬
|
Ketamine
| 8件: 2 2, 4, 6, 13, 70, 113, 156, 215 💬 |
8 |
GRIN2B
💬
| 19件: Ras signaling pathway Ras signaling pathway, Rap1 signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Circadian entrainment, Long-term potentiation, Glutamatergic synapse, Dopaminergic synapse, Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Spinocerebellar ataxia, Prion disease, Pathways of neurodegeneration - multiple diseases, Cocaine addiction, Amphetamine addiction, Nicotine addiction, Alcoholism, Systemic lupus erythematosus | Esketamine
Esketamine
💬
|
Esketamine
| 3件: 2 2, 4, 70 💬 |
9 |
GRIN2B
💬
| 19件: Ras signaling pathway Ras signaling pathway, Rap1 signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Circadian entrainment, Long-term potentiation, Glutamatergic synapse, Dopaminergic synapse, Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Spinocerebellar ataxia, Prion disease, Pathways of neurodegeneration - multiple diseases, Cocaine addiction, Amphetamine addiction, Nicotine addiction, Alcoholism, Systemic lupus erythematosus | Ketamine
Ketamine
💬
|
Ketamine
| 8件: 2 2, 4, 6, 13, 70, 113, 156, 215 💬 |
10 |
GRIN2C
💬
| 15件: Calcium signaling pathway Calcium signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Circadian entrainment, Long-term potentiation, Glutamatergic synapse, Alzheimer disease, Amyotrophic lateral sclerosis, Spinocerebellar ataxia, Prion disease, Pathways of neurodegeneration - multiple diseases, Cocaine addiction, Amphetamine addiction, Nicotine addiction, Alcoholism | Esketamine
Esketamine
💬
|
Esketamine
| 3件: 2 2, 4, 70 💬 |
11 |
GRIN2C
💬
| 15件: Calcium signaling pathway Calcium signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Circadian entrainment, Long-term potentiation, Glutamatergic synapse, Alzheimer disease, Amyotrophic lateral sclerosis, Spinocerebellar ataxia, Prion disease, Pathways of neurodegeneration - multiple diseases, Cocaine addiction, Amphetamine addiction, Nicotine addiction, Alcoholism | Ketamine
Ketamine
💬
|
Ketamine
| 8件: 2 2, 4, 6, 13, 70, 113, 156, 215 💬 |
12 |
GRIN2D
💬
| 15件: Calcium signaling pathway Calcium signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Circadian entrainment, Long-term potentiation, Glutamatergic synapse, Alzheimer disease, Amyotrophic lateral sclerosis, Spinocerebellar ataxia, Prion disease, Pathways of neurodegeneration - multiple diseases, Cocaine addiction, Amphetamine addiction, Nicotine addiction, Alcoholism | Esketamine
Esketamine
💬
|
Esketamine
| 3件: 2 2, 4, 70 💬 |
13 |
GRIN2D
💬
| 15件: Calcium signaling pathway Calcium signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Circadian entrainment, Long-term potentiation, Glutamatergic synapse, Alzheimer disease, Amyotrophic lateral sclerosis, Spinocerebellar ataxia, Prion disease, Pathways of neurodegeneration - multiple diseases, Cocaine addiction, Amphetamine addiction, Nicotine addiction, Alcoholism | Ketamine
Ketamine
💬
|
Ketamine
| 8件: 2 2, 4, 6, 13, 70, 113, 156, 215 💬 |
14 |
KCNA4
💬
| 2件: Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome | Dalfampridine
Dalfampridine
💬
|
Dalfampridine
| 5件: 3 3, 4, 6, 13, 14 💬 |
15 |
KCNC3
💬
| 1件: Spinocerebellar ataxia Spinocerebellar ataxia | Dalfampridine
Dalfampridine
💬
|
Dalfampridine
| 5件: 3 3, 4, 6, 13, 14 💬 |
16 |
KCND2
💬
| 1件: Serotonergic synapse Serotonergic synapse | Dalfampridine
Dalfampridine
💬
|
Dalfampridine
| 5件: 3 3, 4, 6, 13, 14 💬 |
17 |
KCND3
💬
| 1件: Spinocerebellar ataxia Spinocerebellar ataxia | Dalfampridine
Dalfampridine
💬
|
Dalfampridine
| 5件: 3 3, 4, 6, 13, 14 💬 |
18 |
SV2A
💬
| 1件: ECM-receptor interaction ECM-receptor interaction | Levetiracetam
Levetiracetam
💬
|
Levetiracetam
| 5件: 2 2, 4, 6, 13, 307 💬 |